Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31336 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2024. Written by Jane Koo and 6 co-authors. Institution: Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation, Invasive Fungal Infections, Transplantation, Autologous. 12 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Pediatric and young adult patients undergoing autologous hematopoietic stem cell transplant (auto‐HSCT) face a crucial, yet understudied, risk of invasive fungal infections (IFI), especially compared to allogeneic transplants. This gap underscores the need for research in pediatric patients undergoing auto‐HSCT. Our objective was to evaluate the incidence of IFI in pediatric and young adult patients during the first year after auto‐HSCT. Materials and methods We conducted a single‐center retrospective analysis of 150 pediatric and young adult auto‐HSCT patients who underwent transplant from January 2013 to January 2023. We focused on IFI incidence within the first‐year post transplant, using the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria for IFI identification.
Results
Among the 150 patients analyzed, with 240 unique transplant episodes, the primary indication was neuroblastoma (37.3%), and micafungin was extensively used for prophylaxis (82.7%). There was an absence of IFI from yeast and mold species, suggesting a low IFI risk in this cohort. The incidence of IFI in pediatric auto‐HSCT recipients receiving micafungin primary antifungal prophylaxis is rare.
Conclusions
The findings advocate for further research to refine prophylaxis guidelines and highlight the need for individualized risk assessment to optimize post‐transplant care.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID profiles: Jane Koo, John Huber, Priscila Badia, Stella M Davies, Christopher E Dandoy
Cite
APA
Koo, J., Huber, J., Badia, P., Dunseath, C., O'Connor, G., Davies, S. M., & Dandoy, C. E. (2024). Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31336
Vancouver
Koo J, Huber J, Badia P, Dunseath C, O'Connor G, Davies SM, et al. Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31336
BibTeX
@article{Koo2024,
author = {Koo, Jane and Huber, John and Badia, Priscila and Dunseath, Chloe and O'Connor, Gabby and Davies, Stella M and Dandoy, Christopher E},
title = {Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31336}
}
EUVIMED